Edition:
United Kingdom

ImmunoGen Inc (IMGN.OQ)

IMGN.OQ on NASDAQ Stock Exchange Global Select Market

9.98USD
6:43pm BST
Change (% chg)

$-0.01 (-0.10%)
Prev Close
$9.99
Open
$10.00
Day's High
$10.11
Day's Low
$9.95
Volume
191,101
Avg. Vol
790,146
52-wk High
$13.41
52-wk Low
$4.81

Select another date:

Fri, May 4 2018

BRIEF-ImmunoGen Reports Q1 Loss Per Share $0.30

* IMMUNOGEN REPORTS RECENT PROGRESS AND FIRST QUARTER 2018 OPERATING RESULTS

BRIEF-Immunogen Completes Interim Analysis For Forward I Phase 3 Trial Of Mirvetuximab Soravtansine

* IMMUNOGEN ANNOUNCES SUCCESSFUL COMPLETION OF INTERIM ANALYSIS FOR FORWARD I PHASE 3 TRIAL OF MIRVETUXIMAB SORAVTANSINE IN PLATINUM-RESISTANT OVARIAN CANCER

BRIEF-Immunogen Inc Files For Potential Mixed Shelf Offering‍​

* IMMUNOGEN INC FILES FOR POTENTIAL MIXED SHELF OFFERING; SIZE NOT DISCLOSED - SEC FILING‍​ Source text (http://bit.ly/2DablVK) Further company coverage:

BRIEF-Immunogen Inc Reports Qtrly Net Loss Per Common Share, Basic And Diluted Of $0.11‍​

* IMMUNOGEN REPORTS PIPELINE PROGRESS AND 2017 OPERATING RESULTS

Select another date: